Astellas Pharma

Pharmaceuticals · Biopharmaceutical R&D · Japan

Astellas Pharma is a Tokyo-based global pharmaceutical company that researches, develops and commercializes prescription medicines. Its marketed portfolio serves patients in oncology, ophthalmology, urology, immunology and women’s health, with major brands including XTANDI, PADCEV, IZERVAY, VYLOY, VEOZAH/VEOZA and XOSPATA. The company earns revenue primarily from medicine sales and related commercial arrangements.

Its research pipeline spans small molecules, antibody-drug conjugates, cell and gene therapies, protein degraders and other modalities, targeting cancers, retinal diseases and additional conditions with unmet medical needs.